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Abstract The lymphatic clearance pathways of the brain
are different compared to the other organs of the body and
have been the subject of heated debates. Drainage of brain
extracellular fluids, particularly interstitial fluid (ISF) and
cerebrospinal fluid (CSF), is not only important for volume
regulation, but also for removal of waste products such as
amyloid beta (Ab). CSF plays a special role in clinical
medicine, as it is available for analysis of biomarkers for
Alzheimer’s disease. Despite the lack of a complete
anatomical and physiological picture of the communica-
tions between the subarachnoid space (SAS) and the brain
parenchyma, it is often assumed that Ab is cleared from the
cerebral ISF into the CSF. Recent work suggests that
clearance of the brain mainly occurs during sleep, with a
specific role for peri- and para-vascular spaces as drainage
pathways from the brain parenchyma. However, the
direction of flow, the anatomical structures involved and
the driving forces remain elusive, with partially conflicting
data in literature. The presence of Ab in the glia limitans in
Alzheimer’s disease suggests a direct communication of
ISF with CSF. Nonetheless, there is also the well-described
pathology of cerebral amyloid angiopathy associated with
the failure of perivascular drainage of Ab. Herein, we
review the role of the vasculature and the impact of vas-
cular pathology on the peri- and para-vascular clearance
pathways of the brain. The different views on the possible
routes for ISF drainage of the brain are discussed in the
context of pathological significance.
Keywords Perivascular ! Paravascular ! Interstitial fluid !
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Introduction
Extracellular fluid of the brain comprises cerebrospinal
fluid (CSF) in the ventricles and subarachnoid space (SAS)
and interstitial fluid (ISF) in the extracellular spaces (ECS)
of the brain parenchyma. In humans, there are 280 ml of
ISF and 140 ml CSF, of which 30 ml are in the ventricles,
80 ml in the cerebral SAS and 30 ml in the spinal SAS
(Bozanovic-Sosic et al. 2001). CSF acts as a buoyancy
fluid for the human brain and, considering that specific
gravities of the brain and CSF are similar, CSF effectively
reduces the weight of the brain in the skull. CSF is pro-
duced by active secretion from the choroid plexuses in the
ventricles and is resorbed by arachnoid villi. It is however
becoming clear that this traditional view on CSF circula-
tion is too simplistic and much more complex than previ-
ously thought. The reader is referred to an excellent review
on this topic by (Brinker et al. 2014). Apart from the
choroid plexuses as the major anatomical feature respon-
sible for the production of CSF, how much CSF may also
be derived from ISF is uncertain (Hladky and Barrand
2014). Recent evidence suggests a role for paravascular
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circulation of CSF into the brain parenchyma (Iliff et al.
2012). Here we aim to discuss the recent data on CSF and
ISF circulation with a focus on the role of the peri- and
para-vascular routes. We subsequently discuss how the
experimental evidence maps against the evidence from
neuropathological studies.
Cerebrospinal Fluid (CSF)
The mean rate of CSF production in humans is 0.3–0.4 ml/
min (500–600 ml/day) and the total volume of CSF is
replaced every 5–7 h (Di Chiro 1964; Milhorat 1975). The
composition of CSF is determined by the local metabolism,
by the restriction of intercellular diffusion and specialized
transport mechanisms at the blood-CSF and blood–brain
barriers and the rates of CSF production and excretion by
bulk flow. Compared to plasma, the concentrations of
sodium, chloride and magnesium in the CSF are higher, but
the concentrations of potassium, calcium, phosphate,
bicarbonate and glucose are lower. The total protein con-
centration of CSF is \0.5 % of that of plasma (Abbott
2004). Sodium and chloride are actively transported across
the epithelial cells of the choroid plexus; water follows the
concentration gradient passively. Large molecules are
transported by pinocytosis from the basal to the apical
surface of choroidal epithelial cells and then exocytosed
into the ventricular CSF. To some extent, molecules can
also be cleared from the CSF via the choroid plexus, via
specific transporters that are also present at the blood–brain
barrier (BBB). Examples of these are members of the ATP-
binding cassette transporters and Solute Carrier families,
but also peptide transporters (de Lange 2004). An impor-
tant difference is that in contrast to endothelium at the
BBB, the endothelium in the choroid plexus is fenestrated,
resulting in highly permeable capillaries. However, as
reviewed by (Damkier et al. 2013), a tight barrier is formed
by the epithelial cells at the surface of the choroid plexus.
Compared to the knowledge on the BBB, information
about the barrier between blood and CSF is still relatively
sparse.
The circulation of CSF through the lateral and third
ventricles lined by ciliated cuboidal epithelium and through
the aqueduct of Sylvius to the fourth ventricle and into the
SAS has been reviewed recently (Brinker et al. 2014). As
demonstrated by flow-sensitive MRI, CSF motion is pul-
satile and related to intracranial blood vessel pulsations,
resulting in a relatively small net flow of CSF from the
ventricles towards the SAS (Enzmann and Pelc 1993). In
humans, the SAS occupies a few millimetres over the
cerebral gyri and is more extensive in the cisterns located
at the base of the brain. The arachnoid layer of the
meninges is composed of several layers of cells joined by
desmosomes; the outer layer contains tight junctions,
rendering the arachnoid impermeable to CSF (Alcolado
et al. 1988).
Tracer studies in primates demonstrate that CSF drains
via arachnoid villi and granulations into the blood of
venous sinuses (Weed 1923). In the rat, rudimentary
arachnoid villi could serve as a route of direct drainage of a
small proportion of CSF into the blood. Tracers injected
into the CSF flow along channels in the SAS, alongside
leptomeningeal arteries, to the cribriform plate through
which they enter nasal lymphatics and reach the cervical
lymph nodes within 1 min (Kida et al. 1993). Ventricular
injection studies show that radiolabelled insulin-like
growth factor-1 is found within 1 h confined mainly to the
walls of leptomeningeal arteries (Thorne et al. 2004b). The
route through the cribriform plate follows the olfactory
nerves (Nagra et al. 2006; Kida et al. 1993). Using Microfil
as a CSF tracer, (Johnston et al. 2004) filled the sub-
arachnoid compartment of different species, via injection
into the cisterna magna. They observed a similar pathway
in seven different species, from small rodents to humans,
with Microfil distribution throughout the subarachnoid
compartment associated with the base of the brain, in the
basal cisterns in all species and also commonly in the SAS.
Microfil distributed further via the cribriform plate into the
lymphatic vessels of the olfactory and respiratory submu-
cosa, underlining the presence of a lymphatic network that
connects with cervical lymph nodes. Lymphatic vessels
were described in 1987 in the dura mater, adjacent to the
venous sinuses and draining across the cribriform plate
(Andres et al. 1987). Recently, these findings have been
confirmed in rodents, using fluorescent markers for lym-
phatic vessels and confocal microscopy that allowed the
detection of these markers in relation to the dural sinuses
(Aspelund et al. 2015; Louveau et al. 2015). The relative
contribution of all these pathways for the drainage of CSF
has not yet been established. However, for humans it has
been hypothesized to be 1/3 via spinal vessels, 1/3 via the
cribriform plate and 1/3 via the arachnoid granulations
(Veening and Barendregt 2010).
Interstitial Fluid (ISF)
Electron microscopy has shown that very narrow gaps
separate the cells of the nervous system (Hrabeˇtova´ and
Nicholson 2004; Morris et al. 2014). The gaps are inter-
connected and are filled with interstitial fluid; they repre-
sent the ECS that is in direct continuity with the basement
membranes of capillaries (Fig. 1). The most significant
exchange between blood and central nervous system (CNS)
occurs at the capillary level. The cerebral capillary
endothelial cells connected by tight junctions form the
BBB. As recently reviewed by (Hladky and Barrand 2014),
the consequence of this barrier function is that the filtration
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of solutes and water is considerably lower in the brain than
in peripheral tissues. Formation of ISF is highly dependent
on active transport of solutes across the BBB. This does
allow a more controlled bidirectional exchange of mole-
cules between the blood and the brain tissue. Nutrients,
ions, oxygen, together with other fundamental molecules
for CNS metabolism cross the BBB from blood towards the
brain tissue. After crossing the BBB, the molecules diffuse
over short distances of 8–25 lm to the surrounding cells
comprising the CNS. In addition, the capillary endothelium
also presents an efflux route with specific membrane
transporters for the substances that the brain must clear
away (e.g. Ab, lipid soluble toxins). The movement of
water mixed with the movement of solutes (e.g. Ab) results
in the flow of ISF (Abbott 2004, 2013). After entering the
basement membrane at the capillary level, ISF drains along
the basement membranes of cerebral arteries by bulk flow,
as indicated by tracer experiments (Carare et al. 2008).
Bulk flow of ISF was also reported along the white matter
axon tracts (Abbott 2004). Nonetheless, the movement of
ISF through the ECS surrounding the cells of nervous
system depends on diffusion (Sykova´ and Nicholson 2008;
Nicholson et al. 2011). Functionally, the ECS provides a
pathway for the diffusion and exchange of ions and
molecules between cells.
The most widely used method for studying diffusion is
the real-time iontophoretic method TMA (tetramethylam-
monium) (Nicholson 1992). Molecules execute ‘‘random
walks’’ through the ECS; diffusion of solutes in the ECS is
hindered by the presence of cells and their processes. The
apparent diffusion coefficient (D") compared to the
diffusion coefficient in water (D) is measured by tortuosity
(k). Tortuosity in the ECS is a dimensionless value defined
as k ¼ ðD=D"Þ1=2; tortuosity is sensitive to factors like
viscosity of the interstitial fluid and molecular size.
Due to the close apposition of cells, their processes and
junctions, the hindrance (tortuosity) encountered by dif-
fusing molecules in the grey matter is higher compared to
the white matter. Furthermore, movement of molecules
through the ECS is size dependent. Thus, small molecules
(Mw B 6600 Da) are less hindered in their passage
through the brain ECS than proteins with a
Mw C 10,000 Da. Within different regions of the brain
there are differences in the tortuosity in the grey matter; for
example, the tortuosity in the hippocampus is significantly
lower than that in the neocortex (Thorne et al. 2004a). In
the white matter diffusion is facilitated by its structure
consisting of parallel fibres with few interconnections;
consequently, oedema fluid can be accommodated in the
spaces between white matter fibres but not in the grey
matter. Recent experimental work suggests that the
dimension of the ECS during sleep increases by 60 % in
mice but this still remains to be clarified and confirmed by
other studies (Xie et al. 2013). These values remain unaf-
fected by increasing age, despite that fact that ageing
results in profound morphological changes of the cells of
the grey matter (Kress et al. 2014). Once concerning
aspect, that has not yet been clarified, is the amount of
brain swelling due to the suggested expansion of ECS
during sleep.
The extracellular matrix of the brain contains long,
unbranched polysaccharide chains, each composed of
repeating disaccharide units. One of the disaccharide units
is an amino sugar: N-acetyl glucosamine or N-acetyl
galactosamine; collectively, the polysaccharide chains are
therefore named glycosaminoglycans (GAGs). GAG chains
are negatively charged due to the presence of carboxyl,
hydroxyl and sulphate groups. GAGs are hydrophilic due
to their highly negatively charged groups; they attract
water and positive ions, particularly sodium, contributing
to the composition of interstitial fluid.
Aquaporins (AQP) are water-selective channels that
regulate osmotically driven water transport through cell
membranes. AQP1 is present on the epithelial cells of the
choroid plexus, AQP4 is present on the astrocyte foot
processes and ependymal cells and AQP9 is localized in
tanycytes and astrocyte end-feet. Along with cotransporters
of ions and neurotransmitters located on astroglia and
neurons, AQP are key factors in regulating water
homoeostasis in the ECS. Diffusion is faster in mice
lacking aquaporin 4 (AQP4), indicating that the movement
of solutes is inversely proportional to the water content of
the ECS (Nagelhus and Ottersen 2013). APQ4 is highly
Fig. 1 Electron micrograph showing the continuity between the
extracellular spaces and the basement membrane of a cerebral
capillary. The extracellular space between the astrocyte end-feet (Ast)
is emphasized by a star and communicates directly with the
cerebrovascular basement membranes (CVBM). 24-week Wiskar rat
cortical capillary. Magnification: 950,000, scale bar 500 nm
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expressed in the astrocytic end-feet, and appears to be
crucial for the exchanges between the CSF and ISF, as
deletion of AQP4 results in a decrease of movement along
the walls of arteries into the parenchyma (Iliff et al. 2012).
Recent results also show dysregulation of polarization
around penetrating arteries in the ageing brain (Kress et al.
2014). In the latter study, the loss of AQP4 polarization
during ageing was associated with impairment of the CSF
to circulate at these locations after cisternal injections,
highlighting the contribution of this channel to CSF cir-
culation in the brain. It should be noted, however, that
deletion of AQP4 may alter CSF production by the
ependymal cells (Li et al. 2009).
Diffusional properties of the brain are altered by disease.
Confocal microscopy studies using fluorescently labelled
dextrans show that diffusion in the cortex is reduced in
ischaemia (Hrabetova et al. 2003; Sherpa et al. 2014).
There is some controversy regarding the role for hydro-
static pressure-driven water flow through astrocyte end-
feet, compared to osmotic pressure gradients (Thrane et al.
2015; Smith et al. 2015). As shown by in vivo magnetic
resonance imaging studies, APP transgenic mice have a
reduced ECS diffusion coefficient compared to age-mat-
ched controls. This reduction is more obvious in cortical
areas that possess more frequent and severe amyloid
deposits along cerebral arteries as CAA, and not significant
in the striatum where Ab deposits are few and diffuse in
nature (Mueggler et al. 2004). Transplanting embryonic
neural cells from transgenic and wild-type mice into the
neocortex and hippocampus of wild-type and APP23 young
transgenic hosts, resulted in early amyloid deposition only
in the transplants in young transgenic hosts. This suggests
that diffusion of soluble Ab into the ECS of the graft is
dependent on the pre-existent pathology in the ECS of the
host. Thus, it becomes clear that ageing and neuropatho-
logical conditions alter the geometry of the ECS, leading to
altered diffusion (Meyer-Luehmann et al. 2003).
The main sources of ISF are the blood and CSF. Water
generated as a result of oxidation of glucose to CO2 could
provide a 10 % contribution to the total volume of ISF, but
transport from blood across the endothelium could also be
responsible (Abbott 2004). It has been proposed that a large
fraction of ISF is derived from the blood, through the
capillary endothelium, driven by the Na, K ATPase, with
water following passively. In addition to water, ISF con-
sists of tissue metabolites and secreted proteins, including
Ab. Bulk flow of ISF occurs along perivascular pathways
and axon tracts. The rate of bulk flow has been reported to
be 0.1–0.3 ll min-1 g-1 in the rat brain (Abbott 2004). It
has been suggested that the water crossing the BBB may in
fact be taken up by astrocytes, as they express high levels
of AQP4. Tracer experiments and mathematical models
show that ISF is eliminated from the brain by bulk flow and
this occurs along white matter axon tracts and perivascular
pathways (Schley et al. 2006; Cserr et al. 1981, 1977).
Evidence for Drainage of ISF Along Perivascular
Pathways
Tracers such as horseradish peroxidase, Indian ink and I131-
albumin injected into the brain parenchyma enter perivas-
cular pathways. Earlier studies showed that ISF movement
within the perivascular pathways was slow and may have a
variable direction compared to the direction of blood flow
in the lumen of blood vessels (Rennels et al. 1985).
Physiological studies in which a variety of tracers were
injected into mammalian brains suggest that size, shape or
charge of the tracer is more likely to influence the rate of
drainage than molecular weight, confirming that ISF
elimination from the brain is by bulk flow.
Tracer experiments were extremely valuable in high-
lighting the physiological role of perivascular drainage but,
due to the absence of confocal and multiphoton micro-
scopy, did not provide clear information regarding the
exact position of the ISF tracer in the vessel wall Cserr
et al. (1981, 1977). Injections of solutes into the cerebral
hemispheres at appropriate concentrations have focused on
the kinetics of the removal of tracer from the brain and not
on the anatomical route of the elimination pathways. As
drainage of proteins and fluid from the brain occurs along
blood vessel walls and appears to reach cervical lymph
nodes, it is necessary to describe what is known about the
structure of blood vessel walls and their perivascular
spaces, including their cellular content.
Structure of Cerebral Blood Vessels
The brain is supplied by the paired internal carotid arteries
and vertebral arteries. The arteries lie within the SAS and
form the circle of Willis at the base of the brain. Some
branches of the circle of Willis supply the deep grey matter
structures such as the basal ganglia and thalamus, while
branches of the leptomeningeal arteries penetrate the sur-
face of the brain. The latter arteries bifurcate into cortical
arteries, which further branch into arterioles and capillaries
supplying the cerebral cortex. It is of importance to
emphasize that cerebral arteries may differ in structure.
The particular structure of these arteries could influence the
pathway followed by ISF, waste products and tracers
injected experimentally in the brain parenchyma. Excellent
reviews that comprise the particular characteristics and
changes in arterial structure during neurodegeneration are
presented by (Weller et al. 2009a; Weller 2005). Individ-
ually, the blood vessels in the mouse have a similar
structure to those in the human brain (Lee 1995).
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Capillaries
Capillary walls in the human brain are formed by an
endothelium and a basement membrane, separating it from
the brain ECS. The junctions between adjacent endothelial
cells form zonulae occludentes that are the morphological
basis for the BBB. Fibrous astrocytes form end-feet that
completely surround the capillary surface: 40–100 nm
separate the astrocyte end-feet from the endothelium and
this space is occupied by basement membrane (Engelhardt
and Coisne 2011). The layer of basement membrane
adjacent to the endothelial cell and the layer of basement
membrane adjacent to the astrocyte end-feet are fused. The
capillary basement membrane is in direct communication
with the brain extracellular spaces (Fig. 1). Moreover, the
capillary basement membrane is also shared with pericytes,
contractile cells that together with the endothelial cells and
astrocytes are involved in the regulation of the BBB per-
meability (Winkler et al. 2011). Further on, the active role
of the contractile pericytes in the regulation of capillary
diameter and of cerebral blood flow in response to neural
activity has been experimentally validated recently (Bell
et al. 2010; Peppiatt et al. 2006).
Arteries
A normal cerebral artery wall has an endothelium separated
from layers of smooth muscle cells by basement mem-
brane. Basement membrane is also interposed between
individual smooth muscle cells, and between the smooth
muscle layers and the leptomeningeal sheath, comparable
to the adventitia in systemic arteries. The basement mem-
brane of the glia limitans separates the astrocyte end-feet
from the leptomeningeal sheath. The smooth muscle cells
within the arterial wall present contractile properties of
fundamental importance for the regulation of cerebral
blood flow. They are able to respond to mechanical
(pressure), electrical, chemical and hormonal stimuli (La-
colley et al. 2012). The adhesion of the vascular cells to
their basement membranes is essential for maintaining the
integrity of the arterial wall and for recognizing and inte-
grating the high variety of signals that modulate the cell
function (Stegemann et al. 2005).
Vascular Basement Membranes
Vascular basement membranes are 100 nm laminar matri-
ces produced by endothelial and epithelial cells. The
smooth muscle cells from the arterial wall also produce and
organize their own basement membrane. In addition to
providing a potential pathway for the clearance of solutes
out of the brain, the extracellular matrix, including the
vascular basement membrane, determines the mechanical
properties of the vessel wall and controls the migration and
differentiation of vascular cells. In the brain, basement
membranes have been reported to be secreted by meningeal
cells and contribute to the migration and final positioning
of neurons and to the differentiation of the laminar cortical
pattern during development (Wagenseil and Mecham 2009;
Morris et al. 2014). Basement membranes are composed
mainly of collagen type IV, laminin, fibronectin and hep-
aran sulphate proteoglycans. The basement membrane is a
dynamic complex, capable of remodelling itself. In vitro,
type IV collagen, laminin and fibronectin are capable of
assembly into a protein network resembling basement
membranes and are interdependent in the formation of the
basement membranes (Yurchenco and Schittny 1990).
Meninges and Subarachnoid Space
The meninges contribute to the preservation of CNS
homoeostasis, and constitute of three membranes: the dura
mater being the outermost, followed by the arachnoid and
the pia mater as the closest to the brain. The SAS is the
interval between the arachnoid and the pia mater. The SAS
forms cisterns, when the pia mater follows the brain cur-
vatures and separates from the arachnoid. The cisterna
pontis and the cisterna magna are the biggest, but other
smaller cisterns are found in the SAS. The SAS includes
not only CSF, but also the leptomeningeal vessels and the
arachnoid trabeculae. The latter extend between the
arachnoid and the pia mater. They cushion the brain and
protect the cerebral blood vessels from rupture. Moreover,
the trabeculae might be considered as an anatomical
obstacle in the pathway of the CSF flow. Because of the
complex geometry, many modelling studies neglected the
presence of the trabeculae. An extensive network of lym-
phatic vessels, with role in draining solutes from the brain
into the deep cervical lymph nodes, has been observed in
the mouse brain meninges (Aspelund et al. 2015; Louveau
et al. 2015; Andres et al. 1987).
Perivascular Spaces
The perivascular spaces were described by Virchow and
Robin as being in direct communication with the ECS of
the brain and with the SAS. This communication between
the extracellular brain compartment and the SAS provided
a basis for the interpretation that oedema fluid cleared into
CSF. The description of the classical Virchow–Robin space
has been subsequently challenged and modified. Studies of
human brain show that leptomeningeal cells, identified by
the presence of desmosomes and small nexus junctions, are
reflected from the surface of the brain to coat arteries and
veins in the SAS thus separating CSF in the SAS from
brain and perivascular spaces (Weller 2005). Furthermore,
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leptomeningeal cells form a perivascular sheath around
blood vessels in the brain. Peri-arterial spaces are separate
from the SAS and subpial space; however, venous
perivascular spaces communicate with the subpial space.
Cerebral peri-arterial spaces are in direct continuation with
peri-arterial spaces of leptomeningeal vessels that continue
as a layer of perivascular (adventitial) connective tissue
coating arteries as they pass through the skull. As the pia
mater separates the SAS from the potential perivascular
spaces, we do not know whether this has an effect on the
composition of the CSF passing through the pia. The pia
mater stops particles and, probably, neurotransmitter
entering perivascular spaces, but the exact degree of
selective permeability of the pia mater and underlying glia
limitans is not known.
As mentioned earlier, the structure of the arterial wall
and perivascular space differs according to the type of
artery. A cortical artery has a narrow perivascular space
and does not have an elastic lamina, whereas an artery in
the SAS has a large perivascular space and often has an
internal elastic lamina. There are also differences between
perivascular spaces in the human cerebral cortex and the
basal ganglia, as perivascular spaces in the basal ganglia
are enclosed by two layers of leptomeninges. The
anatomical features of the perivascular spaces in laboratory
animals are not well described.
The Perivascular and Paravascular Clearance
Pathways of the Brain
In a very elegant set of experiments, NG2-DS transgenic
mice displaying fluorescent vascular smooth muscle cells
were injected with tracers in the SAS of the cisterna magna
and the pattern of distribution of the tracers was assessed at
30 min after injections were completed (Iliff et al. 2012).
The compartment with observable fluorescent soluble
tracers was along arterial walls, but the exact anatomical
location in relation to the individual components of the
arterial wall is still unclear. Although conventional histol-
ogy was not performed, it appears that the tracers are
present in the compartment enclosed between the pia mater
and glia limitans, enclosing the vascular wall, termed
paravascular. Paravascular entry of soluble tracers from the
CSF appears to be dependent on the expression of AQP4
and on efficient arterial pulsations. Once soluble tracers
reach the brain parenchyma, they disperse and a proportion
is associated with the walls of veins (Iliff et al. 2012,
2013b). Small lipophilic tracers of molecular weights of
under 1 kDa selectively behave slightly differently when
they move from the CSF into the paravascular compart-
ment, as they appear to follow spatially restricted pathways
through the parenchyma. The expression of AQP4 does not
affect this process (Rangroo Thrane et al. 2013).
The movement of CSF along the para-arterial com-
partment into the brain probably represents a slow equili-
bration system between the CSF and ISF compartments,
relying on individual properties of diffusion of pia mater
and glia limitans. This equilibration process is not suffi-
cient to explain the changes observed in the CSF in neu-
rodegenerative diseases such as Alzheimer’s disease,
where a decrease in the concentration of Ab in CSF cor-
relates with the severity of disease (Pirttila et al. 1996).
In contrast to the paravascular pathway outlined by the
studies mentioned above (Iliff et al. 2012), data from the
Carare–Weller group suggest an alternative route along the
vasculature. Thus, in order to define the pathway for the
bulk flow drainage of ISF and solutes from the brain par-
enchyma, minute quantities (0.5 ll) of fluorescent dextran
3 KDa or ovalbumin 49 KDa were injected into the grey
matter of the caudate putamen in the centre of the mouse
cerebral hemisphere (Carare et al. 2008). By 5 min after
injection, tracers had spread diffusely through the ECS but
tracer was also present in the walls of blood vessels.
Confocal microscopy showed that tracers were co-local-
ized with laminin in the basement membranes of capillaries
and in the basement membranes in the tunica media of
arteries (Carare et al. 2008). The location of the tracers in
artery walls was very specific as tracer was only in the
basement membranes between the smooth muscle cells in
the tunica media and not in the endothelial basement
membranes nor in the outer basement membrane encom-
passing the artery wall (Hawkes et al. 2014). Some of the
tracer, particularly 3KDa dextran, was taken up by a few
smooth muscle cells in the tunica media and by perivas-
cular macrophages on the outer aspects of the artery walls.
By 30 min after injection, the tracers had disappeared from
the ECS of the brain and from the basement membranes in
the walls of capillaries and arteries, but tracers remained in
the perivascular macrophages (Carare et al. 2008). By 24 h
after injection, the route taken by the tracers on their pas-
sage out of the brain was outlined by perivascular macro-
phages containing tracer adjacent to intracerebral arteries
and around leptomeningeal arteries on the surface of the
brain (Carare et al. 2008). This route of drainage of solutes
appears to be fast and specific to solutes, as particles in the
range of 20 nm–1 lm do not drain along basement mem-
branes, but rather are engulfed by perivascular macro-
phages (Zhang et al. 1992; Carare et al. 2008). Peri- and
para-vascular spaces along vessels may collapse after
sacrifice of the animal, providing an underestimation of the
actual size of the compartment (Fig. 2).
Multiphoton microscopy imaging of the living mouse
brain during pressure injection of fluorescent tracers into
the brain parenchyma has successfully overcome this hur-
dle (Arbel-Ornath et al. 2013). The tracers aligned very fast
(as soon as 2 min after injection) to the arterial basement
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membrane and were shown to fill the perivascular spaces
within the SMC layer. With high temporal resolution and
minute volume (\0.5 ll per injection) clearance of the
tracers could be tracked at the single vessel level and
showed very rapid clearance (within 30 min) in a biexpo-
nential fashion that would fit with a bulk flow mechanism.
Interestingly, the tracers were only evident in perivascular
spaces along arteries, but never along veins. Experimental
differences with previous reports are that the tracers used
were directly injected to the parenchyma, imaged with very
high temporal resolution and quantitatively assessed from
the real-time data to determine the kinetics in the living
brain. Injecting large (2000 kDa) tracers revealed no
clearance of the tracers associated with the perivascular
space.
Previous studies, using radio-iodinated serum albumin
as a tracer, suggest that once ISF and solutes have left the
brain, they drain along the tunica media and the tunica
adventitia of the major cerebral arteries, through the base
of the skull to deep cervical lymph nodes (Szentistvanyi
et al. 1984). The presence of radioactive tracer in the walls
of intracranial arteries and the absence of tracer in the walls
of the carotid artery in the neck (Szentistvanyi et al. 1984)
strongly supports the suggestion that ISF and solutes leave
the artery walls to drain to adjacent cervical lymph nodes
(Weller et al. 2009b). Quantitative studies of lymphatic
drainage for the brain have shown that the speed of drai-
nage is comparable to that from other organs (Szentistvanyi
et al. 1984). The quantity and volume of tracers injected to
outline the true drainage of ISF from grey matter are too
small to be detected in the cervical lymph nodes. However,
recent experimental evidence from transgenic mice that
overexpress amyloid precursor protein demonstrates that
the amount of Ab in the cervical lymph nodes reflects the
degree of production of mutant Ab in the parenchyma
(Pappolla et al. 2014). Furthermore, recent work from
(Aspelund et al. 2015) shows that tracers injected into the
brain parenchyma drain into the deep cervical lymph nodes
via dural lymphatic vessels.
Motive Force for Perivascular Drainage
The observation that perivascular transport only occurs in
living animals and ceases immediately after cardiac arrest
suggests that pulsations in artery walls may generate the
motive force for the transport of ISF and solutes out of the
brain (Carare et al. 2008). Mathematical models indicate
that perivascular transport of ISF and solutes may be driven
by the contrary (reflection) waves that follow each pulse
wave (Schley et al. 2006). The contrary wave travels in the
reverse direction to the major pulse wave and in the reverse
direction to the flow of blood. If the contrary wave does act
as the motive force for the drainage of ISF and solutes, then
the model dictates that some form of valve-like action is
required in order to prevent reflux during the passage of the
major pulse wave along the vessel wall (Schley et al.
2006). If the route of drainage is within basement mem-
branes (Carare et al. 2008), it is possible that the valve
action results from changes in conformation of the base-
ment membrane, together with biochemical interactions.
Such a change in conformation of the basement membrane
may provide the necessary valve action to ensure that ISF
and solutes are driven centrifugally along the artery walls
and out of the brain (Schley et al. 2006). As vessels age
they become stiff, less elastic and arteriosclerotic, partic-
ularly in humans (Weller et al. 2009a); and such stiffening
may interfere with perivascular drainage of ISF and solutes
in elderly individuals (Weller et al. 2009a). (Iliff et al.
2013b) recently showed that a reduction in pulsatility
reduces paravascular flow, whereas an increase in pul-
satility with dobutamine increased paravascular flow. Thus,
although the work of different groups seems to disagree on
several points, there is consensus on the importance of
arterial pulsations as a motive force.
Fig. 2 Morphology of the
spaces around arteries as
observed by fluorescence
microscopy. Left panel: the
dimensions of the space around
a cortical artery in vivo in the
brain of a mouse. Right panel:
the same vessel immediately
after sacrifice of the mouse,
showing collapse of the
paravascular space. Scale bar
represents 50 lm (Bakker,
Levitski and VanBavel,
unpublished data)
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Recent experimental evidence suggests that focal stroke
as well as amyloid accumulation results in a failure of
perivascular clearance of solutes in the affected hemisphere
(Arbel-Ornath et al. 2013). Thus, it was shown that,
immediately after a stroke, there is a marked impairment of
clearance along occluded vessels compared to the non-
occluded vessels, suggesting that not only pulsations, but
also patent blood flow is necessary for perivascular trans-
port. In agreement with this, it has been shown that cerebral
hypoperfusion in a mouse model of Alzheimer’s disease
leads to accelerated accumulation of Ab in the walls of
leptomeningeal vessels (Okamoto et al. 2012).
Removal of Ab Along Peri- and Para-vascular Pathways
Although it is not yet possible to perform tracer experi-
ments in humans, Ab and other amyloids can be considered
as natural tracers that define the perivascular pathways for
the drainage of ISF and solutes from the human brain
(Weller et al. 2008; Revesz et al. 2003). Ab is deposited as
insoluble plaques in the brains of elderly humans and it
also accumulates in the walls of cerebral arteries and
capillaries as CAA (Lowe et al. 2008). Ab is cleared along
with the ISF and as such eventually aggregates in the
perivascular basement membranes. It is plausible that a
decrease in ISF clearance in the ageing brain predisposes
the perivascular basement membranes to higher concen-
trations of the peptide where it deposited (Kress et al. 2014;
Hawkes et al. 2011). This in turn, increases the stiffness of
the vessels and may further delay ISF clearance and thus
lead to exacerbation of CAA. Indeed, it has been reported
that Ab-expressing transgenic mice, with extensive amy-
loid pathology, both parenchymal and vascular, exhibit
reduced perivascular clearance (Arbel-Ornath et al. 2013).
Deposition of Ab is particularly severe in the brain in
Alzheimer’s disease and is used as one of the pathological
criteria for this disease (Lowe et al. 2008). Produced by
secretase cleavage of the transmembrane protein amyloid
precursor protein (APP) (Selkoe 2001), Ab is eliminated
from the normal brain by several mechanisms. Such
mechanisms include degradation in the brain parenchyma
by the enzymes neprilysin and insulin-degrading enzyme
(Miners et al. 2008) and by absorption into the blood
involving the low density lipoprotein receptor protein-1
pathway (Shibata et al. 2000; Bell et al. 2007) and P-gly-
coprotein (Cirrito et al. 2005). The other major route for
elimination of Ab is along the perivascular lymphatic
drainage pathway (Weller et al. 1998, 2008) that has been
defined by tracer studies in experimental animals described
above (Carare et al. 2008).
The clearance of Ab along the paravascular pathway
was evaluated by Iliff et al., by injecting 125I-labelled Ab in
the brain parenchyma. In their studies, they found that
Aqp4-null mice cleared 125I-labelled Ab from the brain
about 70 % slower than wild-type animals, suggesting a
possible role of Aqp4 in the clearance of the peptide (Iliff
et al. 2012). Besides, they also showed that the clearance of
125I-labelled Ab is greater during sleep (Xie et al. 2013),
and it is significantly impaired in aged brains (Kress et al.
2014). These particular experiments conducted with 125I-
labelled Ab however, do not provide definitive evidence of
drainage of the peptide along the glymphatic pathway, as
the brains need to be homogenized for quantitation. Nev-
ertheless, these results clearly show that clearance of the
brain is impaired with ageing and particularly active during
sleep. Experiments with labelled Ab potentially are better
suited to delineate its removal pathways from the brain.
The work of (Iliff et al. 2012) shows that 1 h after injec-
tion, labelled Ab is found along capillaries and veins,
suggesting outflow along this side of the circulation. An
alternative explanation may however be that immune cells
take up Ab selectively along veins and retain fluorescent
label, as shown by recent data from (Michaud et al. 2013).
One of the advantages of using CAA to study the course
of perivascular drainage is that Ab is deposited in blood
vessel walls as insoluble amyloid, so it can easily be
located by immunocytochemistry or by the use of fluo-
rescent stains such as thioflavin (Revesz et al. 2003; Vin-
ters et al. 1996). Insoluble Ab is deposited in the basement
membranes of capillaries and intracerebral arteries (Weller
et al. 1998, 2008) in exactly the same distribution as the
perivascular pathways outlined by the injection of fluo-
rescent tracers in the mouse brain (Carare et al. 2008). In
arteries of the human cerebral cortex, Ab is deposited in
the basement membranes surrounding smooth muscle cells
in the tunica media but not in the basement membranes of
the arterial endothelium, nor in the basement membranes
on the outer aspects of the artery wall (Weller et al. 2008).
Such sparing of the endothelial basement membranes in
CAA may be significant for the preservation of the
endothelium itself and avoidance of widespread thrombotic
occlusion of arteries with CAA.
Deposits of Ab in the walls of the medium-sized lep-
tomeningeal arteries are seen in tunica media and in the
adventitia (Weller et al. 2009a; Revesz et al. 2003). One
intriguing question is: does Ab drain from brain to cervical
lymph nodes in humans? Evidence from biochemical
studies of soluble Ab in the walls of cerebral arteries
suggest that it does. Ab is present in the walls of
intracranial arteries, even in young adults, but is not
detected in the walls of the carotid artery in the neck
(Shinkai et al. 1995). As in the animal studies (Szentist-
vanyi et al. 1984), this suggests that solutes such as Ab
draining from the brain leave the wall of the carotid artery
for the lymph nodes associated with the carotid artery at the
base of the skull.
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Significance of Perivascular Drainage
for the Pathophysiology of Hydrocephalus
and Syringomyelia
There is an interface between the CSF and ISF not only at
the cortical surfaces of the brain but also at the ventricular
surfaces. The outer surface of the spinal cord is associated
with CSF in the SAS and CSF has access to the central
canal particularly in foetal life.
Obstruction to the flow or absorption of CSF may result
in hydrocephalus with dilatation of the cerebral ventricular
system. In the acute stages of hydrocephalus, particularly
in young children and young animals, periventricular
oedema occurs due to transependymal infusion of CSF
from the ventricles into the white matter. Grey matter areas
adjacent to the ventricles do not show such oedema (Weller
1998). Lesser degrees of periventricular oedema occur in
adults with hydrocephalus and are detectable by MRI;
ventricular shunting or treatment with acetazolamide that
reduces the production of CSF both decrease the severity of
the periventricular oedema in acute hydrocephalus (Alperin
et al. 2014). It appears that perivascular drainage of fluid
from the white matter is not able to adequately compensate
for blockage of CSF drainage. So, not only do the ventri-
cles dilate with accumulated CSF but fluid infused into
periventricular white matter does not drain adequately out
of the brain by the perivascular route.
Similar accumulation of CSF is seen in syringomyelia.
Fluid collects in a syrinx within the spinal cord with
oedema of surrounding cord tissue (Harding and Copp
2008); drainage mechanisms within the spinal cord par-
enchyma do not appear to be adequate to drain such fluid.
One factor responsible for the formation of the syrinx in the
cervical spinal cord appears to be disturbance of normal
free flow of CSF through the foramen magnum with con-
sequent flow of CSF down the central canal of the spinal
cord (Wetjen et al. 2008). It has also been proposed that
CSF enters the spinal cord from an obstructed SAS
alongside arteries, spreads through the parenchyma and
accumulates in the syrinx in the centre of the spinal cord
(Bilston et al. 2010).
Drainage of fluid from cerebral white matter can also be
compromised by blocking peri-arterial drainage pathways
with CAA. Dilatation of perivascular spaces in the white
matter can be observed by MRI in the elderly population
and in Alzheimer’s disease (Charidimou et al. 2015).
Imaging and pathological studies suggest that dilated
perivascular spaces correlate with the severity of CAA in
cortical and leptomeningeal arteries (Charidimou et al.
2015; Roher et al. 2003).
Controversy Regarding the Direction of Peri- and Para-
vascular Flow
A salient issue in the field of peri- and para-vascular flow is the
apparent discrepancy regarding the direction of these two
types of flow. Early papers described a back and forth longi-
tudinal movement of dye, which was slow and variable in
direction (Ichimura et al. 1991). On the other hand, other work
suggested that CSF flows from the SAS in the perivascular
space of penetrating arteries, from where it reaches the basal
lamina of capillaries and thenflows into the brain parenchyma.
From there, it returned to the basal lamina of venules or in the
perivascular space of large veins (Rennels et al. 1985). Thus, a
paravascular inflow of CSF into the brain along arteries, which
mixes with ISF and leaves the brain along veins, has been
proposed (Iliff et al. 2012). Alternatively, a perivascular route
using the extracellular spaces along basement membranes
within the walls of capillaries and arteries that exits the brain,
in the direction opposite to the arterial blood flow has been
suggested (Carare et al. 2008) (Fig. 3).
One possible explanation for these opposite views is that
two pathways exist, being separated by perivascular
meningeal sheets. It would however be rather unlikely that
two pathways exist for drainage of the brain, flowing in
opposite directions. An alternative explanation however, is
that the same pathway is described, but flow directions are
differently interpreted because of methodological differ-
ences. It can be envisioned that the pulsations along
arteries create a mixing action in the peri-/para-vascular
compartment, but do not provide a directional force for
flow per se. Tracers, entering the compartment from the
parenchyma may then spread out of the brain, creating the
impression of flow retrograde to arterial inflow. On the
other hand, tracers injected in the CSF (usually the cisterna
magna) may spread into the brain along the same peri-/-
para-vascular spaces, again as a result of mixing by arterial
and CSF pulsations. This could be interpreted as inflow
into the brain along arteries, following the same direction
of blood flow. Indeed, in most studies in which
parenchymal injections of tracers were used, it was con-
cluded that perivascular flow is outward (Carare et al.
2008), while in the studies in which tracers were injected
into the cisterna magna, inward flow was observed (Iliff
et al. 2012). There are exceptions to this notion, as it was
found that labelled Ab, was detected along capillaries and
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veins after parenchymal injection (Iliff et al. 2012). But in
that case, the initial route of elimination out of the brain
was not determined. Thus, it is possible that differences in
approach may at least partially explain the different find-
ings regarding the direction of the peri-/para-vascular flow.
The idea of mixing within the CSF compartment is actually
Fig. 3 Schematic representation of the peri- and para-vascular spaces
in the human cerebral cortex (not to scale). The subarachnoid space
(SAS), filled with cerebrospinal fluid (CSF), is separated from the
subpial space by the pia matter (Alcolado et al. 1988). A
leptomeningeal sheath (the pial sheath shown in light pink) derived
from the pia matter is also reflected on the walls of both arteries and
veins that are crossing the SAS, thus separating the SAS from the
cerebral cortex. Bundles of collagen are interposed in the subpial
space and form the adventitia of leptomeningeal blood vessels, which
is an expandable perivascular space. The pial sheath surrounding the
leptomeningeal arteries in SAS continues to coat the arteries as they
penetrate the cortex and it is closely applied to the outer basement
membrane of smooth muscle cells (SMCs). Nonetheless, the veins
from the cerebral cortex do not have a coating pial sheath. The middle
layers of basement membrane (dark green), situated between layers of
SMCs, represent the pathway for the perivascular drainage of solutes
out of the brain. As emphasized, solutes do not drain along the inner
or outer basement membrane layers of SMCs (light green). For the
sake of simplicity, we illustrated only one layer of SMCs spiralling
within the arterial wall. The perivascular drainage pathway (green
arrows) follows a similar spiral trajectory which is spanned by a
matrix of proteins. The basement membrane of the glia limitans (dark
grey) is closely applied to the pia matter as the artery enters the brain.
Thus another narrow perivascular space is created between the
irregular surface of the pial sheath and the outer basement membrane
of the SMCs and that of the glia limitans, respectively (Zhang et al.
1990). The narrow perivascular space has also been presented under
the nomenclature of ‘‘paravascular space’’ and it has been proposed to
be part of the glymphatic pathway (dark blue arrows). The cortical
para-arterial pathway was referred to as the Virchow–Robin space
(VRS). However, in the era of electron microscopy the exact
boundaries of the VRS are not clearly defined (Color figure online)
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more in agreement with earlier work, where it was found
that flow in the perivascular space is pulsatile and variable
in direction (Ichimura et al. 1991).
In all cases, the injection of tracers into the brain is very
sensitive to pressure and volume disturbances. In the paper
where the brain’s drainage system was coined as the glym-
phatic pathway, tracers were injected at a rate of 2 ll/min,
injecting a total volume of 10 ll (Iliff et al. 2012). In mice,
total CSF production is estimated as\1 ll/min (Rudick et al.
1982), with a total volume of CSF around 37 ll. Thus, the
normal direction of flow in this compartment may easily be
overwhelmed in such cases, as it was also pointed out in
recent review (Hladky and Barrand 2014). In addition to the
concerns raised in that paper, other points can be made
regarding the concept of glymphatic drainage.
Firstly, the removal of Ab along veins does not correlate
with Ab preferentially depositing along arteries, as is
particularly noticeable in CAA.
Secondly, how does the pulsation of arteries provide
directionality to the paravascular flow? Pulsations alone of
the paravascular space are not expected to create flow. A
mixing action could however be anticipated, as described
above. There appears to be an analogy with the circulation
of blood, but in this case there is no entity identified yet
that fulfils the role of the ‘heart’ as a pump.
Thirdly, when studying the impact of sleep and anaes-
thesia on paravascular flow, it was postulated that varia-
tions in the parenchymal extracellular volume during sleep,
anaesthesia or infusion of a norepinephrine antagonist
determine paravascular inflow. However, could some of the
conditions studied not only alter the dimensions of inter-
stitial spaces, but also CSF production in general? Thus, at
least in humans, sleep is known to be associated with
increased CSF production (Nilsson et al. 1992). In this
manner, paravascular flow and CSF–ISF exchange may not
only change because of effects on interstitial conductance,
but also because of a change in CSF production, which
provides an input into the system.
Fourth, tracers with different molecular size were used
in several studies. Not unexpectedly, large tracers were
found not to penetrate the brain from the paravascular
space. However, when followed in time, large tracers
would then be expected to show a different rate of clear-
ance from the brain, or even accumulate in the paravascular
space due to a sieving action. This was not observed, as the
kinetics of removal from the brain was similar for the small
and large tracers (Iliff et al. 2013a).
Lastly, parts of the anatomical basis for the glymphatic
pathway remain unclear. When injected in the CSF, tracers
follow a ‘‘physically and functionally distinct subcom-
partment’’ of the SAS (Iliff et al. 2012), but the complete
and exact route of drainage of interstitial fluid and its
dynamics in relation to time is still unclear.
Conclusions
In this paper, we have reviewed the pathways for lymphatic
drainage of CSF that are largely separated from the
perivascular pathways for lymphatic drainage of ISF from
the brain parenchyma. Interrelationships between CSF and
ISF have also been emphasized. Combining physiological
studies with examination of the anatomical pathways for
lymphatic drainage of the brain and CSF is essential for
understanding lymphatic clearance in health and disease.
The recent discovery of the dural lymphatic vessels in the
mouse brain (Aspelund et al. 2015; Louveau et al. 2015)
brings new insights on how ISF/CSF from SAS drains into
the cervical lymph nodes. However, the puzzle of the entire
lymphatic system of the brain is still far from being com-
pletely solved. Some missing pieces concern the lymphatic
system within the parenchyma and the existence of an
equivalent dural lymphatic system in the human brain. The
importance of understanding the clearance of solutes from
the brain goes beyond neurodegenerative diseases. Con-
sidering that the BBB is not easily penetrated by the
therapeutic drugs for neurological disorders, additional
methods for delivering the drugs into the brain par-
enchyma, such as direct drug administration to the CSF or
to the brain parenchyma have been employed (Barua et al.
2012; Sampson et al. 2011). However, infusion of thera-
peutic drugs in certain areas of the brain could result in
clearance of the drugs along the proposed peri/paravascular
clearance pathways described above, instead of being
delivered to the targeted tissue (Brady et al. 2013).
Therefore, elucidating the clearance pathways of solutes
from the brain is of paramount importance not only for
understanding the development of neurodegenerative dis-
ease, but also for successful delivery of therapeutic drugs to
the brain tissue targeted for therapy.
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